A Pilot Study to Evaluate the Safety and Efficacy of the Long-acting IL-1 Inhibitor, Rilonacept (IL-1 Trap) in Patients with Familial Cold Autoinflammatory Syndrome (FCAS)

OBJECTIVE: Familial cold autoinflammatory syndrome (FCAS) is caused by mutations in CIAS1 leading to excessive secretion of IL-1β, which is associated with cold induced fevers, joint pain and systemic inflammation. This pilot study was conducted to assess the safety and efficacy of the long acting I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Goldbach-Mansky, Raphaela, Shroff, Sharukh, Wilson, Mildred, Snyder, Christopher, Plehn, Sara, Barham, Beverly, Pham, Tuyet Hang, Kastner, Daniel L., Pucino, Frank, Wesley, Robert A., Papadopoulos, Joanne, Weinstein, Steven, Mellis, Scott
Formato: Artigo
Lenguaje:Inglês
Publicado: 2008
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2875198/
https://ncbi.nlm.nih.gov/pubmed/18668591
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.23620
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares